Skip to main content
TipRanks
Go Ultimate75% OFF

Therapeutic Solutions International (TSOI) Ratios

65 Followers

Therapeutic Solutions International Ratios

TSOI's free cash flow for Q3 2024 was $70.84K. For the 2024 fiscal year, TSOI's free cash flow was increased by $0.00 and operating cash flow was $70.84K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 23Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio0.050.140.450.150.06
Quick Ratio0.030.120.430.150.06
Cash Ratio0.010.010.040.110.01
Solvency Ratio-0.92-1.61-1.17-0.92-0.72
Operating Cash Flow Ratio-0.56-0.46-0.29-0.28-0.13
Short-Term Operating Cash Flow Coverage-1.39-0.96-0.69-0.68-0.32
Net Current Asset Value$ -1.92M$ -1.91M$ -1.40M$ -2.03M$ -2.21M
Leverage Ratios
Debt-to-Assets Ratio0.270.300.641.723.16
Debt-to-Equity Ratio0.790.88-1.36-0.59-0.48
Debt-to-Capital Ratio0.440.473.75-1.41-0.93
Long-Term Debt-to-Capital Ratio0.000.01-0.020.000.00
Financial Leverage Ratio2.932.95-2.13-0.34-0.15
Debt Service Coverage Ratio-1.26-1.75-1.40-1.47-1.01
Interest Coverage Ratio-4.69-5.08-3.77-6.11-2.97
Debt to Market Cap0.240.070.020.080.23
Interest Debt Per Share0.000.000.000.000.00
Net Debt to EBITDA-0.58-0.35-0.43-0.42-0.71
Profitability Margins
Gross Profit Margin62.86%61.58%70.85%79.59%89.03%
EBIT Margin-1817.47%-1562.32%-1609.29%-3027.11%-4897.54%
EBITDA Margin-1502.53%-1444.01%-1596.91%-3015.97%-4873.57%
Operating Profit Margin-2006.67%-1586.03%-1578.79%-2950.78%-3794.02%
Pretax Profit Margin-2245.04%-1874.80%-2028.45%-3509.68%-6173.20%
Net Profit Margin-2191.86%-1844.58%-2029.00%-3509.68%-6173.20%
Continuous Operations Profit Margin-2247.31%-1875.57%-2029.00%-3509.68%-6173.20%
Net Income Per EBT97.63%98.39%100.03%100.00%100.00%
EBT Per EBIT111.88%118.21%128.48%118.94%162.71%
Return on Assets (ROA)-65.91%-105.78%-172.60%-364.54%-545.76%
Return on Equity (ROE)-192.82%-312.18%367.89%123.72%83.40%
Return on Capital Employed (ROCE)-142.66%-235.03%295.19%106.06%51.26%
Return on Invested Capital (ROIC)-91.55%-133.18%-785.89%250.73%99.56%
Return on Tangible Assets-367.80%-632.95%-186.64%-475.03%-1034.71%
Earnings Yield-68.47%-25.14%-4.51%-17.87%-40.05%
Efficiency Ratios
Receivables Turnover5.168.148.7925.689.47
Payables Turnover0.090.190.110.040.01
Inventory Turnover1.631.871.072.370.58
Fixed Asset Turnover0.200.730.460.984.89
Asset Turnover0.030.060.090.100.09
Working Capital Turnover Ratio-0.05-0.13-0.09-0.03-0.01
Cash Conversion Cycle-3724.40-1640.36-3081.42-8668.17-38671.55
Days of Sales Outstanding70.7844.8341.5514.2138.55
Days of Inventory Outstanding224.09194.94341.60154.05627.10
Days of Payables Outstanding4019.271880.143464.578836.4439337.19
Operating Cycle294.87239.78383.15168.27665.65
Cash Flow Ratios
Operating Cash Flow Per Share-0.00-0.00-0.00-0.00-0.00
Free Cash Flow Per Share-0.00-0.00-0.00-0.00-0.00
Dividend Paid and CapEx Coverage Ratio-65.310.00-2.76-121.710.00
Capital Expenditure Coverage Ratio-65.310.00-2.76-121.710.00
Operating Cash Flow Coverage Ratio-1.19-0.94-0.65-0.64-0.32
Operating Cash Flow to Sales Ratio-10.66-4.92-4.93-10.58-11.30
Free Cash Flow Yield-33.81%-6.71%-1.49%-5.43%-7.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.46-3.98-22.16-5.60-2.50
Price-to-Sales (P/S) Ratio32.0173.36449.66196.43154.13
Price-to-Book (P/B) Ratio2.8212.42-81.53-6.92-2.08
Price-to-Free Cash Flow (P/FCF) Ratio-2.96-14.90-67.01-18.42-13.64
Price-to-Operating Cash Flow Ratio-3.00-14.90-91.29-18.57-13.64
Price-to-Earnings Growth (PEG) Ratio0.03-0.26-2.660.220.10
Enterprise Value Multiple-2.71-5.44-28.59-6.93-3.88
Enterprise Value4.03M16.23M66.63M13.10M5.19M
EV to EBITDA-2.71-5.44-28.59-6.93-3.88
EV to Sales40.7078.48456.54209.00188.87
EV to Free Cash Flow-3.76-15.94-68.03-19.60-16.71
EV to Operating Cash Flow-3.82-15.94-92.69-19.76-16.71
Tangible Book Value Per Share-0.00-0.00-0.00-0.00-0.00
Shareholders’ Equity Per Share0.000.00-0.00-0.00-0.00
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.00-0.00-0.00-0.00-0.00
Tax Burden0.980.981.001.001.00
Interest Burden1.241.201.261.161.26
Research & Development to Revenue5.666.975.458.971.01
SG&A to Revenue10.658.5411.0521.3437.82
Stock-Based Compensation to Revenue4.007.959.1718.6017.02
Income Quality0.490.280.240.300.18

Currency in USD